AI Verdict
REX has stronger fundamentals based on our AI analysis.
RGBPP vs REX Fundamental Comparison
| Metric | RGBPP | REX |
|---|---|---|
| Revenue | $59,065.0 | $650.5M |
| Net Income | $-967,853.0 | $83.0M |
| Net Margin | -1,638.6% | 12.8% |
| ROE | N/A | 13.6% |
| ROA | -408.2% | 10.4% |
| Current Ratio | 0.03x | 5.94x |
| Debt/Equity | N/A | 0.02x |
| EPS | $-0.01 | $2.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGBPP vs REX: Frequently Asked Questions
Is RGBPP or REX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REX has stronger fundamentals. RGBPP is rated STRONG SELL (95% confidence) while REX is rated HOLD (75% confidence). This is not investment advice.
How does RGBPP compare to REX fundamentally?
Regen BioPharma Inc has ROE of N/A vs REX AMERICAN RESOURCES Corp's 13.6%. Net margins are -1,638.6% vs 12.8% respectively.
Which stock pays higher dividends, RGBPP or REX?
RGBPP has a dividend yield of N/A or no dividend while REX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGBPP or REX for long term?
For long-term investing, consider that RGBPP has STRONG SELL rating with 95% confidence, while REX has HOLD rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGBPP vs REX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGBPP vs REX, the AI consensus favors REX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.